|Podcasts|June 18, 2009
Rewards for Subjects, an Ethical Dilemma?
Advertisement
Rewards for Subjects, an Ethical Dilemma?
Felix Gyi, PharmD, MBA, CEO of Chesapeake Research Review discusses ethical rewards for patients in clinical studies and how the relationships between pharma and health care professionals affects subject recruitment and retention.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Medidata, BioRender Announce New AI Partnerships Expanding Capabilities in Life Sciences
2
Rethinking Trial Access in Lower-Income Regions Through Patient-Centric, AI-Driven Models
3
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape
4
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
